CLINICAL_TRIALS
trial_result
· 2013-12-13
Clinical Trial Update: Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma [Phase 2]
Summary
Phase 2 trial evaluating sunitinib in advanced or recurrent malignant pleural mesothelioma has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Mesothelioma, Recurrent Malignant Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-13